# Nautilus Biotechnology: Biotechnology, San Carlos, United States

> Nautilus Biotechnology: Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

Source: https://millionrounds.com/startup/nautilus-biotechnology (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Nautilus Biotechnology

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

Funding reported Last round: Post ipo equity

Biotechnology San Carlos, United States

Company summary

- **Founded:** 2016 10 years old
- **Team:** 101 51 to 200 people
- **Funding reported:** $303M in dollars
- **Last round:** Post ipo equity Jun 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Nautilus Biotechnology has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Nautilus Biotechnology raised

Funding, as reported

Reported in all **$303M** in dollars

Rounds **3**

Last round **Post ipo equity**

Last round date **Jun 2021**

Investors listed **15**

## Founders and team

From Nautilus Biotechnology's own website and the SEC filings it signed: 1 founder, 7 on the team.

**Sujal Patel** Founder & CEO *Named on its 2021 Form D*

- **Gwen Weld** Chief People Officer
- **Anna Mowry** Chief Financial Officer
- **Amber Faust** VP, Global Sales
- **Matthew S. Murphy** Executive Officer i
- **Nicholas S. Nelson** Executive Officer i
- **Parag Mallick** Executive Officer, Director i
- **Subra S. Sankar** Executive Officer i

On the board, as filed i *Farzad Nazem* *Matthew Posard* *Matthew S. McIlwain* *Melissa Epperly* *Michael Altman* *Vijay Pande*

## On a portfolio page

Investors who name them

- [Madrona Venture Group](https://millionrounds.com/fund/madrona)

Each firm lists Nautilus Biotechnology on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Nautilus Biotechnology in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)